X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (35121) 35121
Book Review (5066) 5066
Publication (1680) 1680
Newsletter (503) 503
Conference Proceeding (104) 104
Book / eBook (61) 61
Book Chapter (53) 53
Magazine Article (50) 50
Web Resource (13) 13
Trade Publication Article (11) 11
Dissertation (8) 8
Reference (6) 6
Transcript (6) 6
Newspaper Article (5) 5
Data Set (3) 3
Journal / eJournal (2) 2
Government Document (1) 1
Paper (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (33136) 33136
humans (22474) 22474
immunosuppressive agents - pharmacology (15840) 15840
animals (15725) 15725
male (13422) 13422
immunosuppressive agents - therapeutic use (11624) 11624
female (11414) 11414
immunology (10989) 10989
transplantation (10692) 10692
surgery (8510) 8510
mice (7158) 7158
adult (7108) 7108
pharmacology & pharmacy (6899) 6899
middle aged (6221) 6221
immunosuppressive agents (5562) 5562
rats (5355) 5355
immunosuppressive agents - administration & dosage (4036) 4036
time factors (3927) 3927
immunosuppressive agents - adverse effects (3706) 3706
cyclosporine (3228) 3228
kidney transplantation - immunology (3126) 3126
cyclosporine - pharmacology (3091) 3091
cyclosporine - therapeutic use (2943) 2943
immunosuppression (2921) 2921
tacrolimus (2917) 2917
drug therapy, combination (2811) 2811
treatment outcome (2790) 2790
immunosuppressive agents - pharmacokinetics (2780) 2780
aged (2715) 2715
retrospective studies (2495) 2495
cells, cultured (2494) 2494
kidney transplantation (2394) 2394
abridged index medicus (2352) 2352
graft rejection - prevention & control (2294) 2294
dose-response relationship, drug (2293) 2293
transplantation, homologous (2221) 2221
adolescent (2180) 2180
tacrolimus - pharmacology (2153) 2153
analysis (2075) 2075
tacrolimus - therapeutic use (2026) 2026
t-lymphocytes - immunology (1914) 1914
follow-up studies (1887) 1887
therapy (1877) 1877
mice, inbred c57bl (1868) 1868
lymphocyte activation - drug effects (1867) 1867
kidneys (1862) 1862
expression (1849) 1849
mycophenolic acid - analogs & derivatives (1845) 1845
recipients (1831) 1831
mice, inbred balb c (1780) 1780
sirolimus - pharmacology (1700) 1700
immunotherapy (1683) 1683
immunosuppressive agents - blood (1656) 1656
child (1650) 1650
pharmacokinetics (1620) 1620
t-lymphocytes - drug effects (1619) 1619
research (1585) 1585
health aspects (1571) 1571
graft survival - drug effects (1522) 1522
biochemistry & molecular biology (1458) 1458
risk factors (1450) 1450
kidney transplantation - physiology (1445) 1445
cyclosporine-a (1438) 1438
disease models, animal (1410) 1410
activation (1398) 1398
rapamycin (1387) 1387
toxicology (1357) 1357
graft rejection - immunology (1352) 1352
sirolimus (1335) 1335
cells (1321) 1321
lymphocytes (1284) 1284
pharmacology (1268) 1268
inflammation (1261) 1261
graft survival (1254) 1254
mycophenolic acid - therapeutic use (1254) 1254
rejection (1237) 1237
apoptosis (1230) 1230
drugs (1230) 1230
rats, inbred lew (1221) 1221
cyclosporine - administration & dosage (1210) 1210
drug therapy (1189) 1189
fk506 (1187) 1187
calcineurin inhibitors (1157) 1157
cell biology (1145) 1145
liver (1123) 1123
inhibition (1115) 1115
disease (1100) 1100
rats, sprague-dawley (1094) 1094
drug interactions (1093) 1093
cancer (1092) 1092
care and treatment (1084) 1084
oncology (1082) 1082
young adult (1073) 1073
azathioprine - therapeutic use (1063) 1063
medicine, research & experimental (1062) 1062
t cells (1061) 1061
administration, oral (1057) 1057
cyclosporine - pharmacokinetics (1054) 1054
in-vitro (1051) 1051
rats, wistar (1022) 1022
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (46) 46
Online Resources - Online (15) 15
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
UofT at Mississauga - Stacks (2) 2
Gerstein Science - May be requested in 6-10 wks (1) 1
Gerstein Science - Periodical Stacks (1) 1
Gerstein Science - Theses (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (34078) 34078
German (361) 361
Russian (314) 314
Chinese (246) 246
French (240) 240
Japanese (211) 211
Spanish (102) 102
Italian (98) 98
Polish (59) 59
Czech (22) 22
Hungarian (21) 21
Portuguese (13) 13
Dutch (12) 12
Romanian (11) 11
Ukrainian (9) 9
Croatian (7) 7
Bulgarian (5) 5
Danish (3) 3
Hebrew (3) 3
Korean (2) 2
Norwegian (2) 2
Serbian (2) 2
Swedish (2) 2
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Neurology, The, ISSN 1474-4422, 2014, Volume 13, Issue 6, pp. 545 - 556
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 07/2014, Volume 289, Issue 30, pp. 21082 - 21097
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2012, Volume 56, Issue 11, pp. 5728 - 5734
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 09/2008, Volume 118, Issue 9, pp. 3065 - 3074
Journal Article
Nature Chemistry, ISSN 1755-4330, 04/2019, Volume 11, Issue 4, pp. 342 - 350
Journal Article
JAMA Dermatology, ISSN 2168-6068, 07/2017, Volume 153, Issue 7, pp. 681 - 685
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 04/2012, Volume 71, Issue 4, pp. 575 - 581
Objectives Osteoarthritis is associated with cell death and extracellular matrix degradation in articular cartilage. Autophagy is an essential cellular... 
MAMMALIAN TARGET | LIFE-SPAN | AGING-RELATED LOSS | MUTANT HUNTINGTIN | IN-VIVO | DISEASE | MOUSE | MICE | RHEUMATOLOGY | MTOR | CARTILAGE | Arthritis, Experimental - drug therapy | TOR Serine-Threonine Kinases - metabolism | Immunosuppressive Agents - therapeutic use | Male | Osteoarthritis - drug therapy | Autophagy - drug effects | Arthritis, Experimental - metabolism | Arthritis, Experimental - pathology | Anti-Inflammatory Agents - therapeutic use | Osteoarthritis - pathology | Immunosuppressive Agents - pharmacology | Chondrocytes - metabolism | ADAMTS5 Protein | Drug Evaluation, Preclinical - methods | Sirolimus - therapeutic use | Anti-Inflammatory Agents - pharmacology | Mice, Inbred C57BL | Osteoarthritis - metabolism | Treatment Outcome | Sirolimus - pharmacology | Cartilage, Articular - pathology | ADAM Proteins - metabolism | Animals | Signal Transduction - drug effects | Mice | Autophagy (Cytology) | Care and treatment | Rapamycin | Dosage and administration | Models | Research | Osteoarthritis | Protein kinases | Knee | Antigens | Enzymes | Aging | Homeostasis | Calcification | Arthritis | Inflammation | Kinases | Gene expression | Autophagy | Apoptosis | Immunohistochemistry | TOR protein | Synovitis | Phosphorylation | Cartilage (articular) | Joint diseases | Synovium | Signal transduction | Cell death | ribosomal protein S6 | Interleukin 1 | Immunofluorescence | Ligaments | Phagocytosis | Cartilage diseases | Index Medicus | mTOR | autophagy | osteoarthritis | cartilage | rapamycin
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 2/2018, Volume 57, Issue 2, pp. 191 - 207
Alemtuzumab is a humanized monoclonal antibody against CD52 and causes depletion of T and B lymphocytes, monocytes, and NK cells. Alemtuzumab is registered for... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | ACUTE REJECTION | MULTIPLE-SCLEROSIS | POPULATION PHARMACOKINETICS | B-CELL DEPLETION | CHRONIC LYMPHOCYTIC-LEUKEMIA | TACROLIMUS MONOTHERAPY | PHARMACOLOGY & PHARMACY | RENAL-TRANSPLANTATION | ANTI-CD52 MONOCLONAL-ANTIBODY | ANTITHYMOCYTE GLOBULIN INDUCTION | CAMPATH-1H TREATMENT | Antineoplastic Agents, Immunological - administration & dosage | Alemtuzumab - administration & dosage | Antineoplastic Agents, Immunological - pharmacokinetics | Humans | Immunosuppressive Agents - pharmacokinetics | Alemtuzumab - pharmacokinetics | Treatment Outcome | Basiliximab - pharmacology | Kidney Transplantation - methods | Antineoplastic Agents, Immunological - pharmacology | Animals | Basiliximab - administration & dosage | Graft Survival - drug effects | Alemtuzumab - pharmacology | Immunosuppressive Agents - pharmacology | Immunosuppressive Agents - administration & dosage | Chronic lymphocytic leukemia | Care and treatment | Usage | Kidneys | Analysis | Pharmacology | Transplantation | Pharmacokinetics | Multiple sclerosis | Dendritic cells | Transplants & implants | Guillain-Barre syndrome | Leukemia | Cytotoxicity | FDA approval | Granulocytes | Lymphocytes | Stem cells | Bone marrow | Monoclonal antibodies | Lymphomas | Drug dosages | Immune system | Index Medicus | Review
Journal Article